| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Jan 25 | GLUE Monte Rosa Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 11,850 | 0.00 | 25,794 |
| 2 Jan 25 | GLUE Monte Rosa Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 7.11 | 53,400 | 379.67 k | 53,400 |
| 5 Jul 24 | GLUE Monte Rosa Therapeutics | Common Stock | Sell | Dispose S | No | No | 3.8301 | 1,610 | 6.17 k | 13,944 |
| 3 Jun 24 | GLUE Monte Rosa Therapeutics | Common Stock | Sell | Dispose S | No | No | 4.0396 | 1,207 | 4.88 k | 15,554 |
| 2 Jan 24 | GLUE Monte Rosa Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.71 | 35,900 | 204.99 k | 35,900 |
| 2 Jan 24 | GLUE Monte Rosa Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.71 | 25,000 | 142.75 k | 25,000 |
